The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation
The lower urinary tract (LUT) functions as a dynamic reservoir that is able to store urine and to efficiently expel it at a convenient time. While storing urine, however, the bladder is exposed for prolonged periods to waste products. By acting as a tight barrier, the epithelial lining of the LUT, t...
Saved in:
Published in | Journal of visualized experiments no. 66; p. e3869 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
MyJove Corporation
21.08.2012
|
Subjects | |
Online Access | Get full text |
ISSN | 1940-087X 1940-087X |
DOI | 10.3791/3869 |
Cover
Abstract | The lower urinary tract (LUT) functions as a dynamic reservoir that is able to store urine and to efficiently expel it at a convenient time. While storing urine, however, the bladder is exposed for prolonged periods to waste products. By acting as a tight barrier, the epithelial lining of the LUT, the urothelium, avoids re-absorption of harmful substances. Moreover, noxious chemicals stimulate the bladder's nociceptive innervation and initiate voiding contractions that expel the bladder's contents. Interestingly, the bladder's sensitivity to noxious chemicals has been used successfully in clinical practice, by intravesically infusing the TRPV1 agonist capsaicin to treat neurogenic bladder overactivity. This underscores the advantage of viewing the bladder as a chemosensory organ and prompts for further clinical research. However, ethical issues severely limit the possibilities to perform, in human subjects, the invasive measurements that are necessary to unravel the molecular bases of LUT clinical pharmacology. A way to overcome this limitation is the use of several animal models. Here we describe the implementation of cystometry in mice and rats, a technique that allows measuring the intravesical pressure in conditions of controlled bladder perfusion. After laparotomy, a catheter is implanted in the bladder dome and tunneled subcutaneously to the interscapular region. Then the bladder can be filled at a controlled rate, while the urethra is left free for micturition. During the repetitive cycles of filling and voiding, intravesical pressure can be measured via the implanted catheter. As such, the pressure changes can be quantified and analyzed. Moreover, simultaneous measurement of the voided volume allows distinguishing voiding contractions from non-voiding contractions. Importantly, due to the differences in micturition control between rodents and humans, cystometric measurements in these animals have only limited translational value. Nevertheless, they are quite instrumental in the study of bladder pathophysiology and pharmacology in experimental pre-clinical settings. Recent research using this technique has revealed the key role of novel molecular players in the mechano- and chemo-sensory properties of the bladder. |
---|---|
AbstractList | The lower urinary tract (LUT) functions as a dynamic reservoir that is able to store urine and to efficiently expel it at a convenient time. While storing urine, however, the bladder is exposed for prolonged periods to waste products. By acting as a tight barrier, the epithelial lining of the LUT, the urothelium, avoids re-absorption of harmful substances. Moreover, noxious chemicals stimulate the bladder's nociceptive innervation and initiate voiding contractions that expel the bladder's contents. Interestingly, the bladder's sensitivity to noxious chemicals has been used successfully in clinical practice, by intravesically infusing the TRPV1 agonist capsaicin to treat neurogenic bladder overactivity. This underscores the advantage of viewing the bladder as a chemosensory organ and prompts for further clinical research. However, ethical issues severely limit the possibilities to perform, in human subjects, the invasive measurements that are necessary to unravel the molecular bases of LUT clinical pharmacology. A way to overcome this limitation is the use of several animal models. Here we describe the implementation of cystometry in mice and rats, a technique that allows measuring the intravesical pressure in conditions of controlled bladder perfusion. After laparotomy, a catheter is implanted in the bladder dome and tunneled subcutaneously to the interscapular region. Then the bladder can be filled at a controlled rate, while the urethra is left free for micturition. During the repetitive cycles of filling and voiding, intravesical pressure can be measured via the implanted catheter. As such, the pressure changes can be quantified and analyzed. Moreover, simultaneous measurement of the voided volume allows distinguishing voiding contractions from non-voiding contractions. Importantly, due to the differences in micturition control between rodents and humans, cystometric measurements in these animals have only limited translational value. Nevertheless, they are quite instrumental in the study of bladder pathophysiology and pharmacology in experimental pre-clinical settings. Recent research using this technique has revealed the key role of novel molecular players in the mechano- and chemo-sensory properties of the bladder.The lower urinary tract (LUT) functions as a dynamic reservoir that is able to store urine and to efficiently expel it at a convenient time. While storing urine, however, the bladder is exposed for prolonged periods to waste products. By acting as a tight barrier, the epithelial lining of the LUT, the urothelium, avoids re-absorption of harmful substances. Moreover, noxious chemicals stimulate the bladder's nociceptive innervation and initiate voiding contractions that expel the bladder's contents. Interestingly, the bladder's sensitivity to noxious chemicals has been used successfully in clinical practice, by intravesically infusing the TRPV1 agonist capsaicin to treat neurogenic bladder overactivity. This underscores the advantage of viewing the bladder as a chemosensory organ and prompts for further clinical research. However, ethical issues severely limit the possibilities to perform, in human subjects, the invasive measurements that are necessary to unravel the molecular bases of LUT clinical pharmacology. A way to overcome this limitation is the use of several animal models. Here we describe the implementation of cystometry in mice and rats, a technique that allows measuring the intravesical pressure in conditions of controlled bladder perfusion. After laparotomy, a catheter is implanted in the bladder dome and tunneled subcutaneously to the interscapular region. Then the bladder can be filled at a controlled rate, while the urethra is left free for micturition. During the repetitive cycles of filling and voiding, intravesical pressure can be measured via the implanted catheter. As such, the pressure changes can be quantified and analyzed. Moreover, simultaneous measurement of the voided volume allows distinguishing voiding contractions from non-voiding contractions. Importantly, due to the differences in micturition control between rodents and humans, cystometric measurements in these animals have only limited translational value. Nevertheless, they are quite instrumental in the study of bladder pathophysiology and pharmacology in experimental pre-clinical settings. Recent research using this technique has revealed the key role of novel molecular players in the mechano- and chemo-sensory properties of the bladder. The lower urinary tract (LUT) functions as a dynamic reservoir that is able to store urine and to efficiently expel it at a convenient time. While storing urine, however, the bladder is exposed for prolonged periods to waste products. By acting as a tight barrier, the epithelial lining of the LUT, the urothelium, avoids re-absorption of harmful substances. Moreover, noxious chemicals stimulate the bladder's nociceptive innervation and initiate voiding contractions that expel the bladder's contents. Interestingly, the bladder's sensitivity to noxious chemicals has been used successfully in clinical practice, by intravesically infusing the TRPV1 agonist capsaicin to treat neurogenic bladder overactivity1. This underscores the advantage of viewing the bladder as a chemosensory organ and prompts for further clinical research. However, ethical issues severely limit the possibilities to perform, in human subjects, the invasive measurements that are necessary to unravel the molecular bases of LUT clinical pharmacology. A way to overcome this limitation is the use of several animal models2. Here we describe the implementation of cystometry in mice and rats, a technique that allows measuring the intravesical pressure in conditions of controlled bladder perfusion. After laparotomy, a catheter is implanted in the bladder dome and tunneled subcutaneously to the interscapular region. Then the bladder can be filled at a controlled rate, while the urethra is left free for micturition. During the repetitive cycles of filling and voiding, intravesical pressure can be measured via the implanted catheter. As such, the pressure changes can be quantified and analyzed. Moreover, simultaneous measurement of the voided volume allows distinguishing voiding contractions from non-voiding contractions3. Importantly, due to the differences in micturition control between rodents and humans, cystometric measurements in these animals have only limited translational value4. Nevertheless, they are quite instrumental in the study of bladder pathophysiology and pharmacology in experimental pre-clinical settings. Recent research using this technique has revealed the key role of novel molecular players in the mechano- and chemo-sensory properties of the bladder. The lower urinary tract (LUT) functions as a dynamic reservoir that is able to store urine and to efficiently expel it at a convenient time. While storing urine, however, the bladder is exposed for prolonged periods to waste products. By acting as a tight barrier, the epithelial lining of the LUT, the urothelium, avoids re-absorption of harmful substances. Moreover, noxious chemicals stimulate the bladder's nociceptive innervation and initiate voiding contractions that expel the bladder's contents. Interestingly, the bladder's sensitivity to noxious chemicals has been used successfully in clinical practice, by intravesically infusing the TRPV1 agonist capsaicin to treat neurogenic bladder overactivity. This underscores the advantage of viewing the bladder as a chemosensory organ and prompts for further clinical research. However, ethical issues severely limit the possibilities to perform, in human subjects, the invasive measurements that are necessary to unravel the molecular bases of LUT clinical pharmacology. A way to overcome this limitation is the use of several animal models. Here we describe the implementation of cystometry in mice and rats, a technique that allows measuring the intravesical pressure in conditions of controlled bladder perfusion. After laparotomy, a catheter is implanted in the bladder dome and tunneled subcutaneously to the interscapular region. Then the bladder can be filled at a controlled rate, while the urethra is left free for micturition. During the repetitive cycles of filling and voiding, intravesical pressure can be measured via the implanted catheter. As such, the pressure changes can be quantified and analyzed. Moreover, simultaneous measurement of the voided volume allows distinguishing voiding contractions from non-voiding contractions. Importantly, due to the differences in micturition control between rodents and humans, cystometric measurements in these animals have only limited translational value. Nevertheless, they are quite instrumental in the study of bladder pathophysiology and pharmacology in experimental pre-clinical settings. Recent research using this technique has revealed the key role of novel molecular players in the mechano- and chemo-sensory properties of the bladder. The lower urinary tract (LUT) functions as a dynamic reservoir that is able to store urine and to efficiently expel it at a convenient time. While storing urine, however, the bladder is exposed for prolonged periods to waste products. By acting as a tight barrier, the epithelial lining of the LUT, the urothelium, avoids re-absorption of harmful substances. Moreover, noxious chemicals stimulate the bladder's nociceptive innervation and initiate voiding contractions that expel the bladder's contents. Interestingly, the bladder's sensitivity to noxious chemicals has been used successfully in clinical practice, by intravesically infusing the TRPV1 agonist capsaicin to treat neurogenic bladder overactivity 1 . This underscores the advantage of viewing the bladder as a chemosensory organ and prompts for further clinical research. However, ethical issues severely limit the possibilities to perform, in human subjects, the invasive measurements that are necessary to unravel the molecular bases of LUT clinical pharmacology. A way to overcome this limitation is the use of several animal models 2 . Here we describe the implementation of cystometry in mice and rats, a technique that allows measuring the intravesical pressure in conditions of controlled bladder perfusion. After laparotomy, a catheter is implanted in the bladder dome and tunneled subcutaneously to the interscapular region. Then the bladder can be filled at a controlled rate, while the urethra is left free for micturition. During the repetitive cycles of filling and voiding, intravesical pressure can be measured via the implanted catheter. As such, the pressure changes can be quantified and analyzed. Moreover, simultaneous measurement of the voided volume allows distinguishing voiding contractions from non-voiding contractions 3 . Importantly, due to the differences in micturition control between rodents and humans, cystometric measurements in these animals have only limited translational value 4 . Nevertheless, they are quite instrumental in the study of bladder pathophysiology and pharmacology in experimental pre-clinical settings. Recent research using this technique has revealed the key role of novel molecular players in the mechano- and chemo-sensory properties of the bladder. |
Author | Everaerts, Wouter Pinto, Silvia Alpízar, Yeranddy A. Talavera, Karel Gevaert, Thomas Voets, Thomas De Ridder, Dirk Nilius, Bernd Uvin, Pieter Boudes, Mathieu |
AuthorAffiliation | TRP Research Platform Leuven (TRPLe), KU Leuven, Belgium Laboratory for Ion Channel Research, Department of Cellular and Molecular Medicine, KU Leuven, Belgium Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven, Belgium |
AuthorAffiliation_xml | – name: Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven, Belgium – name: Laboratory for Ion Channel Research, Department of Cellular and Molecular Medicine, KU Leuven, Belgium – name: TRP Research Platform Leuven (TRPLe), KU Leuven, Belgium |
Author_xml | – sequence: 1 givenname: Pieter surname: Uvin fullname: Uvin, Pieter – sequence: 2 givenname: Wouter surname: Everaerts fullname: Everaerts, Wouter – sequence: 3 givenname: Silvia surname: Pinto fullname: Pinto, Silvia – sequence: 4 givenname: Yeranddy A. surname: Alpízar fullname: Alpízar, Yeranddy A. – sequence: 5 givenname: Mathieu surname: Boudes fullname: Boudes, Mathieu – sequence: 6 givenname: Thomas surname: Gevaert fullname: Gevaert, Thomas – sequence: 7 givenname: Thomas surname: Voets fullname: Voets, Thomas – sequence: 8 givenname: Bernd surname: Nilius fullname: Nilius, Bernd – sequence: 9 givenname: Karel surname: Talavera fullname: Talavera, Karel – sequence: 10 givenname: Dirk surname: De Ridder fullname: De Ridder, Dirk |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22929055$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkV1LwzAUhoNM3Jd_QXLhhQjTNEmbxgthFj8GA8Ft4F1Im1NXaZvZdEL_vZ2bY3rjVQ7k4eU57-mjTmlLQGjokSsmpHfNwkAeoZ4nORmRULx2DuYu6jv3TkhAiR-eoC6lkkri-z00mS8BLxxgm-KocbUtoK4anJV4Vug8xy_WQFm7GzzGs3ptmg13l2tjoMLREgrroHS6zmw5RMepzh2c7t4BWjzcz6On0fT5cRKNp6PE56IeSUMF9RmhNEhDj5uUCmmI5IJwnmqmwaPSI2HMZaJ1TLhhBhIOsQgDkyYiYAN0u81dreMCTNLqVTpXqyordNUoqzP1-6fMlurNfirGw0D4tA242AVU9mMNrlZF5hLIc12CXTtFW73Wru3oX9QjTFDOmL_ROjvU2vv8VN0C51sgqaxzFaR7xCNqc0G1uWCLXf7Bkqz-LrhdJst_w1-VOZm1 |
CitedBy_id | crossref_primary_10_3389_fimmu_2020_00799 crossref_primary_10_3390_biom13081260 crossref_primary_10_7554_eLife_79378 crossref_primary_10_1007_s11255_020_02668_8 crossref_primary_10_1152_ajpregu_00089_2013 crossref_primary_10_3389_fphys_2017_00049 crossref_primary_10_1371_journal_pone_0069550 crossref_primary_10_1002_nau_22742 crossref_primary_10_1016_j_taap_2019_05_018 crossref_primary_10_1038_s41598_019_47407_x crossref_primary_10_3389_fnins_2017_00690 crossref_primary_10_1152_ajpregu_00008_2014 crossref_primary_10_1186_s12894_020_00699_y crossref_primary_10_1038_s41586_018_0823_6 crossref_primary_10_1152_physrev_00005_2019 |
ContentType | Journal Article |
Copyright | Copyright © 2012, Journal of Visualized Experiments 2012 |
Copyright_xml | – notice: Copyright © 2012, Journal of Visualized Experiments 2012 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
DOI | 10.3791/3869 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic AGRICOLA MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology Medicine |
EISSN | 1940-087X |
ExternalDocumentID | PMC3486752 22929055 10_3791_3869 |
Genre | Video-Audio Media Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 223 29L 53G 5GY AAHBH AAHTB AAYXX ABPEJ ACGFO ADBBV AKRSQ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION CS3 DIK E3Z GX1 HYE OK1 RPM SJN CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
ID | FETCH-LOGICAL-c547t-9d272530226f814df279d0947044fa3ae129108b49caab04d3dec4eb786dfc763 |
ISSN | 1940-087X |
IngestDate | Thu Aug 21 13:44:20 EDT 2025 Thu Jul 10 21:56:36 EDT 2025 Fri Jul 11 15:47:04 EDT 2025 Thu Jan 02 22:44:25 EST 2025 Tue Jul 01 05:23:16 EDT 2025 Thu Apr 24 23:01:42 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 66 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c547t-9d272530226f814df279d0947044fa3ae129108b49caab04d3dec4eb786dfc763 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Correspondence to: Karel Talavera at karel.talavera@med.kuleuven.be |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/3486752 |
PMID | 22929055 |
PQID | 1037243356 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3486752 proquest_miscellaneous_2253226229 proquest_miscellaneous_1037243356 pubmed_primary_22929055 crossref_primary_10_3791_3869 crossref_citationtrail_10_3791_3869 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-08-21 |
PublicationDateYYYYMMDD | 2012-08-21 |
PublicationDate_xml | – month: 08 year: 2012 text: 2012-08-21 day: 21 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of visualized experiments |
PublicationTitleAlternate | J Vis Exp |
PublicationYear | 2012 |
Publisher | MyJove Corporation |
Publisher_xml | – name: MyJove Corporation |
References | 15947692 - J Urol. 2005 Jul;174(1):370-4 8496829 - J Pharmacol Exp Ther. 1993 May;265(2):844-50 21661007 - Neurourol Urodyn. 2011 Jun;30(5):636-46 18650315 - Am J Physiol Regul Integr Comp Physiol. 2008 Sep;295(3):R954-60 17991581 - Urology. 2007 Oct;70(4):826-31 15827347 - Am J Physiol Renal Physiol. 2005 Sep;289(3):F604-10 17849480 - Neurourol Urodyn. 2008;27(4):264-73 15538291 - J Urol. 2004 Dec;172(6 Pt 1):2460-4 17948126 - J Clin Invest. 2007 Nov;117(11):3453-62 21717507 - Neurourol Urodyn. 2011 Nov;30(8):1659-65 8106110 - Br J Pharmacol. 1993 Sep;110(1):77-86 15311063 - J Urol. 2004 Sep;172(3):1166-70 3822491 - Pain. 1987 Jan;28(1):109-27 20432320 - Neurourol Urodyn. 2010 Apr;29(4):603-8 20956320 - Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19084-9 20022034 - J Urol. 2010 Feb;183(2):772-9 21315593 - Curr Biol. 2011 Feb 22;21(4):316-21 11857667 - Neurourol Urodyn. 2002;21(2):136-41 |
References_xml | – reference: 21717507 - Neurourol Urodyn. 2011 Nov;30(8):1659-65 – reference: 8106110 - Br J Pharmacol. 1993 Sep;110(1):77-86 – reference: 21315593 - Curr Biol. 2011 Feb 22;21(4):316-21 – reference: 20022034 - J Urol. 2010 Feb;183(2):772-9 – reference: 15538291 - J Urol. 2004 Dec;172(6 Pt 1):2460-4 – reference: 15827347 - Am J Physiol Renal Physiol. 2005 Sep;289(3):F604-10 – reference: 21661007 - Neurourol Urodyn. 2011 Jun;30(5):636-46 – reference: 20432320 - Neurourol Urodyn. 2010 Apr;29(4):603-8 – reference: 11857667 - Neurourol Urodyn. 2002;21(2):136-41 – reference: 17991581 - Urology. 2007 Oct;70(4):826-31 – reference: 3822491 - Pain. 1987 Jan;28(1):109-27 – reference: 17948126 - J Clin Invest. 2007 Nov;117(11):3453-62 – reference: 18650315 - Am J Physiol Regul Integr Comp Physiol. 2008 Sep;295(3):R954-60 – reference: 20956320 - Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19084-9 – reference: 8496829 - J Pharmacol Exp Ther. 1993 May;265(2):844-50 – reference: 15311063 - J Urol. 2004 Sep;172(3):1166-70 – reference: 15947692 - J Urol. 2005 Jul;174(1):370-4 – reference: 17849480 - Neurourol Urodyn. 2008;27(4):264-73 |
SSID | ssj0062058 |
Score | 2.1304638 |
Snippet | The lower urinary tract (LUT) functions as a dynamic reservoir that is able to store urine and to efficiently expel it at a convenient time. While storing... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | e3869 |
SubjectTerms | agonists Animals biomedical research bladder capsaicin catheters epithelium ethics Female humans innervation laparotomy Medicine Mice pathophysiology pharmacology Rats resorption Stimulation, Chemical transient receptor potential vanilloid channels urethra Urinary Bladder - drug effects Urinary Bladder - physiology Urinary Catheterization - methods urine Urodynamics wastes |
Title | The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22929055 https://www.proquest.com/docview/1037243356 https://www.proquest.com/docview/2253226229 https://pubmed.ncbi.nlm.nih.gov/PMC3486752 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbQEBNCQjBgFBgygrcpI7WTOOGtlKExqaiiq1SeqjhxRKQ2qdq0UvvXc2fnVzuQYC9RFbt26-_sO9t33xHywU4kpkSCicS7ruUIJq1QJdLiTAYBqFgRxBg7PPjuXY2d64k7afx0dXRJIS-i3R_jSu6CKrwDXDFK9j-QrRuFF_AZ8IUnIAzPf8Z4bA7j-1uw4uaqWOo4vtEcb5x_5LF2k9DB56OKPfrzDBeb5TlSBeQr2MU22Nw2UjfpCqMud2CWNrkAajN8vDEMBMO07eV7CeMYqmVh_PfydatomGY6bdP5KJ1t0loj9GYLfWH_ZWfcvX9CA1kMP7d30T6VQPcO32LNqcRge51vMO-eYWOu_oYyi2yALqW-mLTky6ReOVzPuQhwPee-SefSgnQx15gyBuadbYh-D3izh4M-RzpBFxT0fSaEvsTXZzlGT3vMdv1j8qjs5iN2gtTQZYv7dsqtzcehD23LKLl5Qh6XQNGeEY2n5J7KTsgDk190e0KOB6XnxDPyDWSFgqzQPKGNrNA0o1pWaCkrn2iPaknBeqWk0H1JeU7GXy9v-ldWmUbDilxHFFYQM8EwORTzEr_rxAmDCQi7emE7ThLyUIHJ17V96QRRGErbiXmsIkdJ4XtxEoH-eUGOsjxTLwl1RWiHUgVcBb6DvEC-lCEXCjb9ypXc75D31aBNo5JjHlOdzKaw18RRnuIod8hZXWthOFUOyt9V4z2FxQ5vsMJM5evVFINamcO56_29DigoUFIe4NghpwajupcK3A4Re-jVFZBsfb8kS39p0vVSll7d-ZuvycNmorwhR8Vyrc7AoC3kWy2XvwFfJKX6 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Use+of+Cystometry+in+Small+Rodents%3A+A+Study+of+Bladder+Chemosensation&rft.jtitle=Journal+of+visualized+experiments&rft.au=Uvin%2C+Pieter&rft.au=Everaerts%2C+Wouter&rft.au=Pinto%2C+Silvia&rft.au=Alp%C3%ADzar%2C+Yeranddy+A.&rft.date=2012-08-21&rft.pub=MyJove+Corporation&rft.eissn=1940-087X&rft.issue=66&rft_id=info:doi/10.3791%2F3869&rft_id=info%3Apmid%2F22929055&rft.externalDocID=PMC3486752 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1940-087X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1940-087X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1940-087X&client=summon |